Assignee
PROVIVA THERAPEUTICS HONG KONG LTD
CN·0 granted patents·11 pending applications·0 citations·filing 2019–2023
Top patents by PatentIndex Score
11 records- 0162US2024182537A1Il-15 procytokine antibody fusion proteinsPROVIVA THERAPEUTICS HONG KONG LTD·Filed 2023·Application pending·0 cites
- 0261US2024218037A1Il-2 procytokine antibody fusion proteinsPROVIVA THERAPEUTICS HONG KONG LTD·Filed 2023·Application pending·0 cites
- 0351US2023399371A1Il-12 compositions and methods of use thereofPROVIVA THERAPEUTICS HONG KONG LTD·Filed 2021·Application pending·0 cites
- 0450US2023257453A1Collagen-targeted fusion proteins and antibodiesPROVIVA THERAPEUTICS HONG KONG LTD·Filed 2021·Application pending·0 cites
- 0550US2023250193A1Antibodies to fibroblast activation protein and b7h3PROVIVA THERAPEUTICS HONG KONG LTD·Filed 2021·Application pending·0 cites
- 0649US2023226202A1Il-2/il15 compositions and methods of use thereofPROVIVA THERAPEUTICS HONG KONG LTD·Filed 2021·Application pending·0 cites
- 0747US2022378933A1Il-2 compositions and methods of use thereofPROVIVA THERAPEUTICS HONG KONG LTD·Filed 2020·Application pending·0 cites
- 0846US2023226203A1Activatable procytokinesPROVIVA THERAPEUTICS HONG KONG LTD·Filed 2020·Application pending·0 cites
- 0941US2022324933A1Il-2 compositions and methods of use thereofPROVIVA THERAPEUTICS HONG KONG LTD·Filed 2020·Application pending·0 cites
- 1040US2022227837A1Il-2 compositions and methods of use thereofPROVIVA THERAPEUTICS HONG KONG LTD·Filed 2020·Application pending·0 cites
- 1139US2023045048A1Il-15 compositions and methods of use thereofPROVIVA THERAPEUTICS HONG KONG LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PROVIVA THERAPEUTICS HONG KONG LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →